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Background: The age- and gender-specific incidence of total hip replacement surgery has increased over the last
two decades in all age groups. Recent studies indicate that non-surgical interventions are effective in reducing pain
and disability, even at later stages of the disease when joint replacement is considered. We hypothesize that the
time to hip replacement can be postponed in patients with severe hip osteoarthritis following participation in a
patient education and supervised exercise program when compared to patients receiving patient education alone.
Methods/design: A prospective, blinded, parallel-group multi-center trial (2 sites), with balanced randomization
[1:1]. Patients with hip osteoarthritis and an indication for hip replacement surgery, aged 40 years and above, will
be consecutively recruited and randomized into two treatment groups. The active treatment group will receive 3
months of supervised exercise consisting of 12 sessions of individualized, goal-based neuromuscular training, and
12 sessions of intensive resistance training plus patient education (3 sessions). The control group will receive only
patient education (3 sessions). The primary end-point for assessing the effectiveness of the intervention is 12
months after baseline. However, follow-ups will also be performed once a year for at least 5 years. The primary
outcome measure is the time to hip replacement surgery measured on a Kaplain-Meier survival curve from time of
inclusion. Secondary outcome measures are the five subscales of the Hip disability and Osteoarthritis Outcome
Score, physical activity level (UCLA activity score), and patient’s global perceived effect. Other measures include pain
after exercise, joint-specific adverse events, exercise adherence, general health status (EQ-5D-5L), mechanical muscle
strength and performance in physical tests. A cost-effectiveness analysis will also be performed.
Discussion: To our knowledge, this is the first randomized clinical trial comparing a patient education plus
supervised exercise program to patient education alone in hip osteoarthritis patients with an indication for surgery
on the time to total hip replacement.
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Osteoarthritis (OA) is the most common joint disease
and a major contributor to pain, decreased physical
function and decline in health-related quality of life [1].
Its incidence and prevalence will increase in the coming
years due to the ageing of the population [2]. Already,
the incidence of total hip replacement in Denmark, has
increased from 75 per 100,000 in 1995 to 170 per
100,000 in 2009 [3], a development likely to continue as
joint replacements are generally recommended at later
stages of the disease and therefore, commonly experienced
as one gets older. Such a development has socio-economic
consequences, and thus, calls for potential non-surgical
treatment alternatives, especially those which are effective
in improving physical function and reducing pain to a level
where health-related quality of life is restored, and the
need for total joint replacement is at best eliminated, or at
least, postponed.
Within the last decade, it has become well established
that exercise reduces pain and improves function in
patients with knee OA [4-12]. A recent meta-analysis on
supervised exercise interventions showed that exercise
had moderate effect on pain and self-reported physical
function in patients with mild to moderate knee OA
[11], and another meta-analysis found similar effects in
those waiting for knee replacement [4]. Supported by
these meta-analyses, exercise is recommended in clinical
guidelines for the management of knee OA across the
severity range of the disease [10]. Conversely, evidence
to support exercise as part of the management of hip OA
is lacking, primarily due to the absence of hip-specific
studies [6,9,13]. Randomized Controlled Trials (RCTs) of
exercise specific to hip OA are one of the top research
priorities of the European League against Rheumatism
(EULAR) [14].
Exercise treatment could potentially be used to
postpone hip replacement surgery. Although, the opti-
mal type of exercise is yet to be determined. An indi-
vidualized approach to exercise prescription is needed
based on assessment of impairments [10]. In addition,
exercise classes are more effective in reducing pain
than home-based programs [15], and both the pro-
gression and intensity should be carefully controlled
as they are the strongest factors affecting functional
outcome [16,17]. Hence, an exercise intervention
aimed at postponing or eliminating surgery should be
individualized, class-based, progression-controlled, and
feasible for patients with severe hip OA.
A program based on neuromuscular principles was
found to be feasible in elderly patients scheduled for hip
and knee replacement, and it complied with the above
recommendations for exercise prescription [18], while
intensive resistance training has proven effective in hip
patients in the early postoperative phase [19]. To mimicperformance enhancement in sports, and possibly to boost
the effect of the intervention, both exercise modalities will
be used in this trial.
In summary, more evidence to support the use of
exercise as non-surgical treatment in the management of
patients with severe hip OA is needed, and its effect on
the time to hip replacement surgery is largely unknown.
Specific objective and hypothesis
The primary aim is to test the hypothesis that patients
with severe hip OA are more likely to postpone hip
replacement surgery following participation in a patient
education and supervised exercise program when com-
pared to patients receiving patient education alone.
The secondary aim is to examine if self-reported mus-
culoskeletal health defined as pain, physical function,
physical activity and quality of life (HOOS), physical
activity level (UCLA activity score), and the patient’s
global perceived effect (GPE) improve more in the
education and exercise group. Other measures include
pain after exercise, joint-specific adverse events, exercise
adherence, general health status (EQ-5D-5L), mechanical
muscle strength and physical performance tests. A cost-
effectiveness analysis will also be performed.
Methods and materials
Study design
A prospective, blinded, parallel-group, multi–center trial
(2 sites), with balanced randomization [1:1], in accordance
with CONSORT (Consolidated Standards of Reporting
Trials) guidelines [20].
Participants and recruitment procedures
Patients aged 40 years and older with an indication for
total hip replacement (THR) for hip OA will be
consecutively recruited from the outpatient clinic at the
Department of Orthopedic Surgery and Traumatology,
Odense University Hospital, and Vejle Hospital, Denmark.
The inclusion and exclusion criteria are listed in Table 1.
The indication for THR will be based upon symptoms, a
clinical examination and radiographic findings [21]. Al-
though, defining the cut points for symptoms and func-
tional disability which indicate the need for a hip
replacement is complex [22]. Data on multiple other fac-
tors such as home situation, co-morbidities, and marital
status will be collected at baseline. An independent radiolo-
gist will assess the stage of hip OA severity using the
Kellgren-Lawrence grading scale [23].
On initial contact, patients will be examined and an
indication for hip surgery will be assessed by an orthopedic
surgeon. Where all inclusion criteria and none of the
exclusion criteria are met, the patients will be invited to
participate and will receive verbal and written information
about the trial (background, procedure, randomization,
Table 1 Criteria for participants in the study
Inclusion criteria Exclusion criteria
40 years and older Inflammatory joint disease
Indication for total
hip replacement
Earlier ipsilateral proximal femur fracture
Residency within local
municipality or willing
to commute
Hip pain < 3 months
Neuropathy or neuromuscular disease
Malignant disease
Diseases where a moderate level of
physical exercise is contraindicated
Inability to speak or read Danish
Inability to participate for other reasons
Refusal to participate
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video without technical or value-laden terms will be
provided to patients to ensure impartiality between treat-
ments and consistency at both hospitals. Information will
be given in an undisturbed location within the outpatient
clinic, and time will be made available for questions.
Subsequently, the patients will receive the written consent
form. Patients wishing to have some reflection time will
be given a stamped addressed envelope, and contacted by
the research nurse no later than 2 days after consultation.
Patients who choose not to have reflection time will sign
the written consent form, be randomized, and scheduled
for the completion of baseline measurements.
A flow diagram of the progress (enrolment, randomization,
intervention allocation, and follow-up and data analysis)
through the trial can be found in Figure 1.
Randomization and allocation concealment
Block randomization will be computer-generated in two
steps by a person (JL) not involved in the trial. At first,
stratification by hospital will be performed. Next, patients
will be allocated to one of the two interventions by a
sequence of letters: A – referring to patient education plus
supervised exercise, and B – referring to patient education
alone. Block sizes will be balanced within 5 blocks of 20
patients in each strata. The allocation sequence will be
concealed in sequentially numbered opaque, sealed envel-
opes. To prevent subversion of the allocation sequence,
the name and date of birth of the participant will be writ-
ten on the envelope. Envelopes will be opened only after
the enrolled patients have completed all baseline assess-
ments and subsequent appointments have been made
based on treatment allocation.
Blinding
Blinding to treatment allocation of patients, physiothera-
pists and nurses (health care providers) will not be possibledue to the nature of the interventions. However, independ-
ent data collectors will be responsible for baseline and
follow-up assessments, while all self-reported outcome
questionnaires will be made available to the patients elec-
tronically, and responses entered into a database identified
by identification numbers only. The data analyst (principal
investigator, CJ) will be unaware of the treatment allocation
as data will be analyzed using recoded identification
numbers. The recoding will be performed by an inde-
pendent person (JL).
Interventions
The active treatment group (EDU+EX) will consist of
patient education and supervised exercise. The control
group (EDU) will consist of patient education only.
Patients in group EDU+EX will receive two types of
exercise, delivered on separate days. One type of exercise is
class-based, individualized, goal-oriented NEuroMuscular
EXercise training for patients who are scheduled for
total joint replacement (NEMEX-TJR). The other type of
exercise will be class-based, individualized, intensive
Resistance Training (RT). Both groups will receive educa-
tion, which will be administered on separate days to ensure
that EDU+EX patients receive education independently
from patients randomized to EDU.
The NEMEX-TJR exercise program
The aim of NEMEX-TJR training is to improve sensori-
motor control and achieve compensatory functional stabil-
ity. Functional, weight-bearing exercises are used in various
positions, resembling conditions of daily living and more
strenuous activities [18]. The program emphasizes neutral
alignment of the hip, knee and foot, and although focus is
on the affected leg, exercises are carried out with both legs.
Progression is guided by the patient’s neuromuscular
function [18] to accommodate the individual’s level of func-
tion and pain. The NEMEX-TJR program has previously
been described in detail and is available for download as an
additional file [18].
The RT exercise program
The aim of intensive resistance training is to improve
functional capacity through improvements in muscle
strength and power. Progression in these exercises is
guided by load [24]. Thus, the quantity of muscle output
and the stimulation of neural adaptation (neural drive) is
emphasized. Multiple and single joint, non-weight-bearing
exercises targeting isolated muscle groups are used. Each
exercise is performed as three sets of 8–12 repetitions
equal to 70-80% of 1 Repetition Maximum (RM) with
time for rest equivalent to that of one set [25-27].
Each of the two types of exercise will be offered weekly
during the 12-week intervention period in sessions lasting
60–70 minutes. Thus, the entire exercise intervention will
Questionnaires, Muscle Strength, Physical Performance
Group A:
Patient education and 
supervised exercise
Group B:
Patient
Education
1 year cumulative survival and intention-to-treat on secondary outcome 
Allocation
Questionnaires, Muscle Strength, Physical Performance
Questionnaires, Muscle Strength, Physical Performance
Analyses
YES
NO
YES
NO
YES
NO
0 months
3 months
12 months
NO
YES
NO
Prospective observational cohort follow-up until at least 5 years after inclusion 
Assessed for eligibility (Odense and Vejle) 
Excluded:
• Meet exclusion criteria
Randomisation
Enrollment
Patient decision:
Based on the information provided do you want 
immediate surgery? 
Indication for surgery (standardized criteria)
Refuse to participate (THA surgery)
YES
Figure 1 Study flow chart through-out the randomized clinical trial.
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continuously into the class-based groups so each group
consists of both novice and experienced participants.
Exercise professionals who are experienced in the execution
of both types of exercise will be responsible for the patient
education and supervised exercise program.
Both types of exercise may provoke pain and patients
will therefore be asked to rate their pain intensity (0=no
pain, 10=worst possible pain) before and after each
session on a visual analogue scale (VAS). In accordance
with the NEXEM-TJR program the patients will be told
that pain up to a level of 5 is considered “acceptable”
after each training session. The day after training, their
pain should subside to ‘pain as usual’ and not increase
over time. ‘Pain as usual’ is defined as the pain level
prior to exercise. If this does not occur, the level of
training progression will be reduced [18].
The patient education program
The patient education program is designed to encourage
the patient to actively engage in and take responsibility
for the management and treatment of their hip OA. The
program is called GLA:D (Good Life with Arthritis in
Denmark), and is based on principles used in The
Osteoarthritis Management Course developed in Sweden
(BOA, Gothenburg, Sweden) [28]. It consists of three
sessions, each with a duration of 90 minutes. The con-
tent of the program has been translated into Danish and
found to be feasible. All physiotherapists will attend a
course in delivering the GLA:D concept to ensure
consistency. Sessions will be held in groups of up to 15
participants. The physiotherapists responsible for con-
ducting the program will facilitate interaction and dis-
cussions between the patients. The education group will
be similarly monitored to the supervised exercise group.
Intervention and follow-up period
Assessments will be made at baseline, 3 and 12 months
after randomization, and both treatment groups will
have completed the intervention after 3 months [29].
After the intervention, patients will be encouraged to
continue the exercise program unsupervised at home or
in public fitness centers.
Outcome measures
One primary outcome measure has been chosen to avoid
problems of interpretation associated with multiplicity
of analysis [30,31]. It will be supported by a range of
self-reported secondary outcome measures.
Primary outcome measure
Cumulative Survival analysis (Kaplan-Meier survival curve).
Cumulative survival is measured as the time in days
without total hip replacement surgery since inclusion.Secondary outcome measures
The Hip disability and Osteoarthritis Outcome Score
(HOOS 2.0)
HOOS is a patient-reported outcome measure with five
subscales for pain, other symptoms, function in daily living,
function in sport and recreation and health-related quality
of life (QoL) [32]. A 5-point Likert-scale will be used and
converted into a 100-point scale with zero indicating the
worst possible health [33].Physical activity level
The University of California Los Angeles activity score
(UCLA activity score) is a 10-point Likert scale recom-
mended and used extensively in similar populations [34,35].Global perceived effect (GPE) score
In addition to pain and physical function, the assessment
by the patient of a global perceived effect of the treat-
ment is a recommended responder criterion [36].
Patients will be asked to rate possible change in their
condition (pain, symptoms, ADL, sport and recreation,
QoL, level of physical activity, treatment evaluation)
since the initial administration (baseline) on a 7-point
Likert scale. A 2-point change from ‘no change’ will be
used as cut-off to categorize the response into: 1) better,
2) no change, and 3) worse, with ‘no change’ being the
neutral response.Other measures
Self-reported exercise pain
Pain will be self-reported immediately before and after
each exercise session using a VAS scale. Pain scores will
be grouped into 0–2 indicating safe, > 2-5 acceptable,
and > 5 high risk pain [18]. Self-reported pain after exercise
will be used to rate the overall percentage of training
sessions completed with acceptable pain, and to evaluate
joint-specific adverse events (detailed later).Exercise adherence
‘The extent to which a person’s behavior corresponds
with agreed recommendations from a health care pro-
vider’ [37]. Adherence will be measured as the number
of training sessions completed out of the expected 24
sessions, and will be analyzed separately for RT and
NEMEX exercises. Excellent adherence will be defined
as participation in 75% or more of the exercise sessions,
good as 50-74%, moderate as 25-49%, and poor when
participation in less than 25% of the sessions. Patients
ceasing training or unwilling to continue will be referred
back to the orthopedic department for an optional total
joint replacement without having to enter into possible
waiting lists.
Jensen et al. BMC Musculoskeletal Disorders 2013, 14:21 Page 6 of 9
http://www.biomedcentral.com/1471-2474/14/21Mechanical muscle strength
Isometric muscle strength (iMVC) for knee extensors,
hip extensors, hip flexors and hip abductors using stabi-
lized dynamometry.
Physical performance battery
Physical performance-based measures will include: 30-
second repeated chair raise test (number completed),
20-meter fast-paced walk (time in seconds), 30-second
single-leg knee bending (number completed), and Timed
Up and Go (time in seconds).
General health status (EQ-5D-5L)
A utility index for use in health economics. It is based
on a descriptive system that defines health in terms of
five dimensions: Mobility, Self-Care, Usual Activities,
Pain/Discomfort, and Anxiety/Depression [38].
Cost-effectiveness
This will be estimated as the ratio between the cost of the
intervention and the effect it produces. The total cost will
be estimated from register-based costing of primary care,
secondary care (length of hospital stay, re-admission, visits
at the emergency room and out-patient clinic) and
patient’s out-of-pocket costs (transportation expenses and
time spent on transportation and receiving health care).
Quality of Life Adjusted Years (QALYs) will be used for
the analysis and calculated using changes in EQ-5D-5L
from baseline to the 12-month follow-up. Patient-reported
values are weighted using Danish tariffs [39].
Poor compliance
Poor compliance is not uncommon in studies of non-
surgical treatments [40]. Achieved exercise dose and
reasons for poor-compliance will be recorded.
Joint-specific adverse events
Joint-specific adverse events will be determined as: 1)
not attending a training session and/or ceasing training
because of increased pain/problems in the index joint
related to the training; and 2) self-reported pain level > 5
on the VAS scale after training. The reasons for not
attending a session due to pain/problems related to
training or to other factors will be recorded.
Sample size
One year has been selected as a clinically relevant period
to postpone surgery. The survival probability in the
education plus exercise group at one year is estimated to
be 0.80 and 0.60 for the education only group. Survival
group differences will be tested using log-rank statistics.
To achieve a statistical power of 80% (β=0.20), the esti-
mated sample size for a two-sample comparison (days
without surgery) of survivor functions (log-rank), asample size of n=86 is needed in each group to detect sta-
tistically significant differences (for α=0.05). Allowing for
no more than 15% drop-out, 200 patients in total will be
recruited.
Statistical analysis
All outcome measures will be checked for Gaussian
distribution, and non-parametric data will be analyzed
using a Mann–Whitney rank sum test [41]. The treat-
ment effect will be analyzed using a random effects
mixed linear model (repeated measures) [42]. Hence,
correlated measurements from the same patient can be
modeled. Model assumptions are checked by residual
plots and the model includes the interaction between
treatment and elapsed time, adjusted for baseline values.
All analysis will follow the intention-to-treat principle
[43]. However, subsequent analysis using last observation
carried forward may be required. Finally, the number
needed to treat (NNT) for a positive effect of treatment
(no surgery after 1 year) will be analyzed. All statistical
analyses are blinded and will be performed using Stata 11
software (StataCorp, TX, USA).
Facilities, organization and timeline
Exercise professionals from the local municipal health
agency will participate. The project utilizes already
established exercise facilities within the municipality.
This collaboration between several health care professionals
enables us to conduct a clinically founded randomized trial
based on evidence from several research areas. The use of a
multi-center design facilitates recruitment, and possible
implementation of a new treatment strategy. Inclusion of
patients will commence 2013 and end 2014 and with the
12 month follow-up, the last patient will be followed-up in
2015. In the continuation of this trial, we intend to follow
patients (prospective observational cohort study) to provide
long-term results (Figure 1).
Ethics
The trial complies with the Declaration of Helsinki and
ethics approval has been granted by the Regional Ethics
Committee of Southern Denmark, approval number
S-20120109. The trial is registered with ClinicalTrials
[44] (NCT01697241).
Discussion
To our knowledge this is the first randomized clinical
trial comparing the effect of a patient education plus
supervised exercise program to education alone on the
time to total hip replacement in patients with an indication
for hip replacement surgery.
Such a trial is warranted because exercise as non-
surgical treatment may help to postpone or eliminate
the need for TJR without deterioration and also improve
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and decreased pain. Hence, studying patients with this
severe disease condition is clinically important. Further,
the primary outcome measure ‘time in days without
surgery’ was chosen because TJR should only be recom-
mended once improvements cannot be achieved by other
treatment strategies. Moreover, postponing or avoiding TJR
is the most relevant outcome when it comes to: reducing
health care costs providing the program is cost-effective,
minimizing complications, and improving healthcare
pathways. Finally, such a trial is also warranted because the
recommendations for lower extremity exercises are based
on studies of knee OA patients. Although exercise trials on
patients with hip OA have been conducted, most of these
studies have also included patients with coexisting knee
OA, and results were not joint-specifically reported, or too
few patients with hip OA were included, preventing valid
conclusions to be drawn [6,9,12,15]. Consequently,
evidence supporting exercise for patients with hip OA
is needed [14].
The secondary outcome measures used in this trial are
those recommended for use in clinical studies of OA,
and include patient-reported outcome measures (PROs)
for pain, physical function, physical activity, health-
related quality of life, and global response to treatment
[36]. The patients will be asked to rate their current hip
condition at baseline, and at each follow up (HOOS
questionnaire), but also to rate possible change in their
condition since baseline (GPE questionnaire). The 3-month
follow-up was chosen to identify possible improvements at
the end of the intervention period. Three months is also a
reasonably long timeframe for clinical improvements to
occur in patients with long-standing hip pain, yet short
enough to assume that patients would be able to recall their
baseline condition. The 12-month follow-up was chosen to
match the clinically relevant period for postponing hip
replacement surgery.
As for the other measures, both muscle mechanical
and physical performance-based outcome measures will
be part of the evaluation for primarily three reasons.
First, muscle mechanic outcomes provide information
about the effectiveness of the exercise intervention in
terms of improving muscle strength, and both muscle
weakness [45] and muscle asymmetry [46,47] have been
found to be present in hip OA patients. Second, physical
performance-based outcomes provide information about
the effectiveness of the exercise intervention in terms of
improved function in tasks resembling daily activities.
Third, muscle atrophy has been associated with functional
limitations in aging individuals [48], and this trial is
adequately powered to further explore such associations.
Furthermore, measures of exercise-related pain, adherence,
and joint-specific adverse events are essential for evaluating
the feasibility of the exercise intervention program. Finally,the cost-effectiveness of non-surgical interventions for hip
OA is needed [49]. Total costs during the first year will be
compared with gains on the HOOS and the patient’s per-
ceived effect (GPE), and the societal costs of the interven-
tion per patient during the first year and the incremental
qualify of life in years/days, as obtained from the EuroQol
(QALY during the first year). The gain in health and the
costs associated with the heath gain could possibly be used
as a decision-making aid for optimal resource allocation.
A number of considerations went into designing the
supervised exercise intervention in this trial. One
consideration was how to prescribe an exercise program,
where the level of progression gradually increases, with-
out provoking persistent pain. The use of self-reported
pain (VAS) immediately after each exercise session has
previously proven to be a feasible way of adjusting the
level of progression [18]. Hence, patients who experience
recurrent high risk pain after exercise or whose pain
either doesn’t return to ‘pain as usual’ or increases during
the day following exercise will be asked to reduce the level
of exercise to the previous level of progression.
Another consideration was selecting the type of exer-
cises to be used in this trial. An exercise program based
on neuromuscular principles has been shown to be
patient- and goal-oriented and feasible for elderly
patients scheduled for hip and knee replacement [18].
All exercises are individualized with progression guided
by the patient’s neuromuscular function, and for each
exercise, three levels of progression are available, mean-
ing the program can be tailored to the individual’s pain
level and function. It utilizes functional exercises and
emphasizes neutral alignment of the hip, knee and foot
to resemble conditions in daily life and more strenuous
activities, without compromising the quality of the
performance. Another exercise program using progres-
sive high load (intensive) resistance training principles
has been shown to be effective in elderly patients in the
early postoperative phase [19] and elderly hospitalized
patients [50]. Also, evidence of the efficacy of general
pre-operative strengthening exercises exists [4], and
strengthening exercises alone show moderate effect on
pain and function in patients with OA [51]. Rather than
using general strengthening exercises, the use of high
load (70-80% of 1RM) in the current trial is based on
evidence from systematic reviews, where the intensity of
the training was the strongest factor affecting strength
and functional outcome [16,17]. To be effective, exer-
cises must target isolated muscle groups, be progressive
[26,27], and possibly be combined with a more complete
exercise program [51]. Both exercise programs in this
trial are supervised, based on individualized goal-based
patient treatment that allows the program to target the
presenting musculoskeletal impairments that contribute
to the patient’s symptoms and functional limitations.
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which recommend tailored treatment [14].
A final consideration was how to most effectively
distribute the two types of exercises throughout the
intervention period, and across each week. We decided to
mimic performance enhancement in sports. As a result,
neuromuscular and intensive resistance exercise sessions
will be administered on separate days within the same
week, so that separate session goals can then be pursued.
Optimal outcomes in population health require both
efficacious treatments and adherence to those treat-
ments. Adherence to health interventions is a complex
issue, especially for individuals with chronic conditions
[52]. The interaction between patients and providers in
terms of verbal communication, physical interaction and
empathy could affect the patient’s enthusiasm, adher-
ence, and participation. Nevertheless, it can be enhanced
by the use of supervised, class-format exercise sessions
in the initial exercise period [10] combined with later
‘refresher or booster’ sessions [52,53]. Also, to minimize
the provider effect, three physiotherapists will randomly
interact and execute the training program at each center
in this trial.
The internal validity of the trial may be affected by a
negative performance bias in the group who receive
patient education only, as they may feel neglected and
missing out on active treatment. The exclusion criteria
always limit the generalizability to other populations.
For example, the results from this trial may not be
generalized to an individual patient with hip OA who is
not fit enough to take part in moderate-to-high intensity
exercise. Conversely, the external validity is improved by
the multi-center design, and the delivery of the interven-
tions by multiple practicing community physiotherapists.
Also, the intervention will be implemented for both
genders, a wide age range, and in patients with severe
hip OA. Hence, it is reasonable to assume that the
program could benefit the general hip OA population.
Lack of adherence is a potential confounding factor for
the outcomes in this trial. Consequently, the number of
sessions completed will be recorded, and patients will be
asked specifically at follow-up points if they have
initiated other treatments for their hip condition since
the last examination [52].
Conclusion
We have designed this randomized clinical trial with the
main purpose being to compare the effect of education
plus supervised exercise to education alone on the time to
hip replacement surgery in patients with an indication for
hip replacement surgery. The results will provide evidence
for the effectiveness of supervised exercise in relation to
the postponement of hip replacement surgery, and the
cost-effectiveness of the intervention. It may also redefinecurrent treatment strategies for patients with severe osteo-
arthritis of the hip.
The results will be submitted to a peer-reviewed inter-
national journal for publication irrespective of the outcome
in accordance with the CONSORT guidelines for reporting
of clinical trials [20,30].
Abbreviations
ADL: Activities of Daily Living; EQ-5D-5L: EuroQol; GPE: Global Perceived
Effect; HOOS: The Hip disability and Osteoarthritis Outcome Score;
iMVC: Isometric Maximal Voluntary Contraction; NEMEX-TJR: Neuromuscular
Exercise for patients eligible for total joint replacement; QoL: Quality of Life;
RT: Resistance Training; TJR: Total Joint Replacement; UCLA: University of
California Los Angeles activity score; VAS: Visual Analog Scale.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
CJ and SO conceived the project and procured the project funding. CJ is
leading the coordination of the trial and is responsible for drafting this
manuscript. ER provided intellectual input on the design of the trial and
provided the training of the study physiotherapists in administering patient
education and neuromuscular exercise. All authors participated in the trial
design, provided feedback on drafts of this protocol and read and approved
the final manuscript.
Acknowledgements
This trial is funded by The Region of Southern Denmark, the Odense
University Hospital Research Counsel, the University of Southern Denmark,
and The Danish Rheumatism Association. None of the funders have any role
in the trial other than to provide funding. We would like to thank the project
nurses for handling the logistics, the team of physiotherapists who
administered the treatment, the municipality of Odense and Vejle for
providing exercise equipment plus facilities, and Jens Lauritsen, who
designed and provided the randomization schedule.
Author details
1Orthopedic Research Unit, Dept. of Orthopedic Surgery and Traumatology,
Odense University Hospital, 29, Sdr. Boulevard, DK-5000, Odense C, Denmark.
2Institute of Clinical Research, University of Southern Denmark, Odense C,
Denmark. 3Musculoskeletal Function and Physiotherapy, Institute of Sports
Science and Clinical Biomechanics, University of Southern Denmark, Odense
C, Denmark. 4Sector for Hip and Knee Replacement, Dept. of Orthopedics,
Vejle Hospital, Vejle, Denmark.
Received: 19 December 2012 Accepted: 9 January 2013
Published: 14 January 2013
References
1. Salaffi F, Carotti M, Stancati A, Grassi W: Health-related quality of life in
older adults with symptomatic hip and knee osteoarthritis: a comparison
with matched healthy controls. Aging Clin Exp Res 2005, 17:255–263.
2. Elders MJ: The increasing impact of arthritis on public health. J Rheumatol
Suppl 2000, 60:6–8.
3. Overgaard S: Annual Rapport 2012; http://www.dhr.dk.
4. Wallis JA, Taylor NF: Pre-operative interventions (non-surgical and non-
pharmacological) for patients with hip or knee osteoarthritis awaiting
joint replacement surgery - a systematic review and meta-analysis.
Osteoarthritis Cartilage 2011, 19:1381–1395.
5. Roddy E, Zhang W, Doherty M, Arden NK, Barlow J, Birrell F, Carr A,
Chakravarty K, Dickson J, Hay E, et al: Evidence-based recommendations
for the role of exercise in the management of osteoarthritis of the hip or
knee–the MOVE consensus. Rheumatology (Oxford) 2005, 44:67–73.
6. Hernandez-Molina G, Reichenbach S, Zhang B, Lavalley M, Felson DT: Effect
of therapeutic exercise for hip osteoarthritis pain: results of a meta-
analysis. Arthritis Rheum 2008, 59:1221–1228.
7. Escalante Y, Saavedra JM, Garcia-Hermoso A, Silva AJ, Barbosa TM: Physical
exercise and reduction of pain in adults with lower limb osteoarthritis:
a systematic review. J Back Musculoskelet Rehabil 2010, 23:175–186.
Jensen et al. BMC Musculoskeletal Disorders 2013, 14:21 Page 9 of 9
http://www.biomedcentral.com/1471-2474/14/218. Brosseau L, MacLeay L, Welch V, Tugwell P, Wells GA: Intensity of exercise
for the treatment of osteoarthritis. Cochrane Database of Systematic
Reviews 2003, (2):CD004259. doi:10.1002/14651858.CD004259.
9. Fransen M, McConnell S, Hernandez-Molina G, Reichenbach S: Does land-
based exercise reduce pain and disability associated with hip
osteoarthritis? A meta-analysis of randomized controlled trials.
Osteoarthritis Cartilage 2010, 18:613–620.
10. Bennell KL, Hinman RS: A review of the clinical evidence for exercise in
osteoarthritis of the hip and knee. J Sci Med Sport 2011, 14:4–9.
11. Fransen M, McConnell S: Land-based exercise for osteoarthritis of the
knee: a metaanalysis of randomized controlled trials. J Rheumatol 2009,
36:1109–1117.
12. Fransen M, McConnell S, Bell M: Therapeutic exercise for people with
osteoarthritis of the hip or knee. A systematic review. J Rheumatol 2002,
29:1737–1745.
13. Fransen M, McConnell S, Hernandez-Molina G, Reichenbach S: Exercise for
osteoarthritis of the hip. Cochrane Database Syst Rev 2009, (3):CD007912.
14. Zhang W, Doherty M, Arden N, Bannwarth B, Bijlsma J, Gunther KP,
Hauselmann HJ, Herrero-Beaumont G, Jordan K, Kaklamanis P, et al: EULAR
evidence based recommendations for the management of hip
osteoarthritis: report of a task force of the EULAR Standing Committee
for International Clinical Studies Including Therapeutics (ESCISIT).
Ann Rheum Dis 2005, 64:669–681.
15. Fransen M, McConnell S, Bell M: Exercise for osteoarthritis of the hip or
knee. Cochrane Database Syst Rev 2003, (3):CD004286.
16. Liu CJ, Latham NK: Progressive resistance strength training for improving
physical function in older adults. Cochrane Database Syst Rev 2009,
(3):CD002759.
17. Latham NK, Bennett DA, Stretton CM, Anderson CS: Systematic review of
progressive resistance strength training in older adults. J Gerontol A Biol
Sci Med Sci 2004, 59:48–61.
18. Ageberg E, Link A, Roos EM: Feasibility of neuromuscular training in
patients with severe hip or knee OA: the individualized goal-based
NEMEX-TJR training program. BMC Musculoskelet Disord 2010, 11:126.
19. Suetta C, Magnusson SP, Rosted A, Aagaard P, Jakobsen AK, Larsen LH, Duus B,
Kjaer M: Resistance training in the early postoperative phase reduces
hospitalization and leads to muscle hypertrophy in elderly hip surgery
patients–a controlled, randomized study. J Am Geriatr Soc 2004, 52:2016–2022.
20. Boutron I, Moher D, Altman DG, Schulz KF, Ravaud P: Extending the
CONSORT statement to randomized trials of nonpharmacologic treatment:
explanation and elaboration. Ann Intern Med 2008, 148(4):295–309.
http://annals.org/issue.aspx?journalid=90&issueID=20154&direction=P.
21. Kjærsgaard-Andersen P, Varmarken J, Gebuhr P, Sturup J, Overgaard S, Søballe
K: Referenceprogram for Total Hofte Alloplastik.: Dansk Ortopædisk Selskab; 2006.
22. Gossec L, Paternotte S, Maillefert JF, Combescure C, Conaghan PG, Davis
AM, Gunther KP, Hawker G, Hochberg M, Katz JN, et al: The role of pain
and functional impairment in the decision to recommend total joint
replacement in hip and knee osteoarthritis: an international cross-
sectional study of 1909 patients. Report of the OARSI-OMERACT Task
Force on total joint replacement. Osteoarthritis Cartilage 2011, 19:147–154.
23. Kellgren JH, Lawrence JS: Radiological assessment of osteo-arthrosis.
Ann Rheum Dis 1957, 16:494–502.
24. Kraemer WJ, Adams K, Cafarelli E, Dudley GA, Dooly C, Feigenbaum MS,
Fleck SJ, Franklin B, Fry AC, Hoffman JR, et al: American College of Sports
Medicine position stand. Progression models in resistance training for
healthy adults. Med Sci Sports Exerc 2002, 34:364–380.
25. Brzycki M: Strength testing: predicting a one-rep max from repetitions to
fatigue. J Phys Educ Recreation, and Dance 1993, 64:88–90.
26. Chodzko-Zajko WJ, Proctor DN, Fiatarone Singh MA, Minson CT, Nigg CR, Salem
GJ, Skinner JS: American College of Sports Medicine position stand. Exercise
and physical activity for older adults. Med Sci Sports Exerc 2009, 41:1510–1530.
27. Rhea MR, Alvar BA, Burkett LN, Ball SD: A meta-analysis to determine the dose
response for strength development. Med Sci Sports Exerc 2003, 35:456–464.
28. Better management of patients with OsteoArthritis. http://www.boaregistret.se.
29. Altman R, Brandt K, Hochberg M, Moskowitz R, Bellamy N, Bloch DA,
Buckwalter J, Dougados M, Ehrlich G, Lequesne M, et al: Design and
conduct of clinical trials in patients with osteoarthritis:
recommendations from a task force of the Osteoarthritis Research
Society. Results from a workshop. Osteoarthritis Cartilage 1996, 4:217–243.
30. Moher D, Hopewell S, Schulz KF, Montori V, Gotzsche PC, Devereaux PJ,
Elbourne D, Egger M, Altman DG: CONSORT 2010 explanation andelaboration: updated guidelines for reporting parallel group randomised
trials. Int J Surg 2012, 10:28–55.
31. Schulz KF, Grimes DA: Multiplicity in randomised trials I: endpoints and
treatments. Lancet 2005, 365:1591–1595.
32. Nilsdotter AK, Lohmander LS, Klassbo M, Roos EM: Hip disability and
osteoarthritis outcome score (HOOS)–validity and responsiveness in total
hip replacement. BMC Musculoskelet Disord 2003, 4:10.
33. Hip Disability and Osteoarthritis Outcome Score (HOOS). http://www.koos.nu.
34. Terwee CB, Bouwmeester W, van Elsland SL, de Vet HC, Dekker J:
Instruments to assess physical activity in patients with osteoarthritis of
the hip or knee: a systematic review of measurement properties.
Osteoarthritis Cartilage 2011, 19:620–633.
35. Zahiri CA, Schmalzried TP, Szuszczewicz ES, Amstutz HC: Assessing activity
in joint replacement patients. J Arthroplasty 1998, 13:890–895.
36. Bellamy N, Kirwan J, Boers M, Brooks P, Strand V, Tugwell P, Altman R, Brandt K,
Dougados M, Lequesne M: Recommendations for a core set of outcome
measures for future phase III clinical trials in knee, hip, and hand osteoarthritis.
Consensus development at OMERACT III. J Rheumatol 1997, 24:799–802.
37. Sabaté E (Ed): Adherence to long-term therapies: evidence for action. Geneva,
Switzerland: World Health Organization; 2003.
38. EuroQol Group. http://www.euroqol.org.
39. Wittrup-Jensen KU, Lauridsen J, Gudex C, Pedersen KM: Generation of a Danish
TTO value set for EQ-5D health states. Scand J Public Health 2009, 37:459–466.
40. Frobell RB, Roos EM, Roos HP, Ranstam J, Lohmander LS: A randomized
trial of treatment for acute anterior cruciate ligament tears. N Engl J Med
2010, 363:331–342.
41. Vickers AJ: Parametric versus non-parametric statistics in the analysis of
randomized trials with non-normally distributed data. BMC Med Res
Methodol 2005, 5:35.
42. Rabe-Hesketh S, Skrondal A: Variance-components models, Multilevel and
Longitudinal Modeling Using Stata. 2nd edition. College Station, Texas: Stata
Press; 2008:51–90.
43. Sainani KL: Making sense of intention-to-treat. PM R 2010, 2:209–213.
44. ClinicalTrials. http://www.ClinicalTrials.gov.
45. Sicard-Rosenbaum L, Light KE, Behrman AL: Gait, lower extremity strength,
and self-assessed mobility after hip arthroplasty. J Gerontol A Biol Sci Med
Sci 2002, 57:M47–M51.
46. Jensen C, Aagaard P, Overgaard S: Recovery in mechanical muscle
strength following resurfacing versus standard total hip arthroplasty - a
randomized clinical trial. Osteoarthritis Cartilage 2011, 19:1108–1116.
47. Rasch A, Bystrom AH, Dalen N, Berg HE: Reduced muscle radiological
density, cross-sectional area, and strength of major hip and knee muscles
in 22 patients with hip osteoarthritis. Acta Orthop 2007, 78:505–510.
48. Janssen I, Heymsfield SB, Ross R: Low relative skeletal muscle mass
(sarcopenia) in older persons is associated with functional impairment
and physical disability. J Am Geriatr Soc 2002, 50:889–896.
49. Pinto D, Robertson MC, Hansen P, Abbott JH: Cost-effectiveness of
nonpharmacologic, nonsurgical interventions for hip and/or knee
osteoarthritis: systematic review. Value Health 2012, 15:1–12.
50. Suetta C, Magnusson SP, Beyer N, Kjaer M: Effect of strength training on
muscle function in elderly hospitalized patients. Scand J Med Sci Sports
2007, 17:464–472.
51. Pelland L, Brosseau L, Wells G, Macleay L, Lambert J, Monthe C, Robinson V,
Tugwell P: Efficacy of strengthening exercises for osteoarthritis (part I):
A meta-analysis. Phys Ther Rev 2004, 9:77–108.
52. Jordan JL, Holden MA, Mason EE, Foster NE: Interventions to improve
adherence to exercise for chronic musculoskeletal pain in adults.
Cochrane Database Syst Rev 2010, (1):CD005956.
53. Pisters MF, Veenhof C, De Bakker DH, Schellevis FG, Dekker J: Behavioural graded
activity results in better exercise adherence and more physical activity than
usual care in people with osteoarthritis: a cluster-randomised trial. J Physiother
2010, 56:41–47.
doi:10.1186/1471-2474-14-21
Cite this article as: Jensen et al.: The effect of education and supervised
exercise vs. education alone on the time to total hip replacement in
patients with severe hip osteoarthritis. A randomized clinical trial
protocol. BMC Musculoskeletal Disorders 2013 14:21.
